Zacks Investment Research upgraded shares of Trupanion Inc (NYSE:TRUP) from a hold rating to a buy rating in a research note published on Wednesday. They currently have $37.00 price target on the financial services provider’s stock.
According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
TRUP has been the topic of several other reports. Canaccord Genuity restated a buy rating and set a $35.00 price objective (up from $29.00) on shares of Trupanion in a research note on Tuesday, October 31st. Cowen and Company restated an outperform rating and set a $28.00 price objective (up from $19.00) on shares of Trupanion in a research note on Wednesday, August 2nd. BidaskClub raised shares of Trupanion from a hold rating to a buy rating in a report on Friday, October 13th. Royal Bank Of Canada lifted their target price on shares of Trupanion from $19.00 to $26.00 and gave the stock an outperform rating in a report on Wednesday, August 2nd. Finally, Stifel Nicolaus reaffirmed a buy rating and set a $24.00 target price (up previously from $18.00) on shares of Trupanion in a report on Wednesday, August 2nd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus target price of $28.83.
Trupanion (TRUP) traded up $0.21 during trading on Wednesday, hitting $30.19. 251,800 shares of the stock traded hands, compared to its average volume of 155,033. Trupanion has a one year low of $13.71 and a one year high of $33.00.
Trupanion (NYSE:TRUP) last released its quarterly earnings data on Thursday, November 2nd. The financial services provider reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.04. The company had revenue of $63.12 million for the quarter, compared to analyst estimates of $61.44 million. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. Trupanion’s revenue for the quarter was up 30.5% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.06) EPS.
TRADEMARK VIOLATION NOTICE: This news story was reported by Markets Daily and is the property of of Markets Daily. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.themarketsdaily.com/2017/11/12/zacks-investment-research-upgrades-trupanion-inc-trup-to-buy.html.
In other Trupanion news, insider Darryl Rawlings sold 3,500 shares of the business’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $22.30, for a total value of $78,050.00. Following the completion of the sale, the insider now owns 1,453,005 shares of the company’s stock, valued at approximately $32,402,011.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Asher Bearman sold 10,900 shares of the business’s stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $22.83, for a total transaction of $248,847.00. Following the completion of the sale, the insider now directly owns 11,539 shares of the company’s stock, valued at approximately $263,435.37. The disclosure for this sale can be found here. Insiders have sold a total of 124,900 shares of company stock valued at $3,162,462 in the last ninety days.
Hedge funds and other institutional investors have recently bought and sold shares of the business. American International Group Inc. boosted its holdings in Trupanion by 7.1% in the 1st quarter. American International Group Inc. now owns 8,864 shares of the financial services provider’s stock valued at $126,000 after purchasing an additional 588 shares during the period. JPMorgan Chase & Co. bought a new stake in Trupanion in the 3rd quarter valued at about $143,000. Bank of Montreal Can boosted its holdings in Trupanion by 309.2% in the 2nd quarter. Bank of Montreal Can now owns 9,044 shares of the financial services provider’s stock valued at $201,000 after purchasing an additional 6,834 shares during the period. Voya Investment Management LLC bought a new stake in Trupanion in the 2nd quarter valued at about $215,000. Finally, Alliancebernstein L.P. boosted its holdings in Trupanion by 1.2% in the 1st quarter. Alliancebernstein L.P. now owns 16,700 shares of the financial services provider’s stock valued at $237,000 after purchasing an additional 200 shares during the period.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.